Group of answer choices.
A. the election of lawmakers to legislate on the people's behalf
B. provisions for first-past-the-post voting
C. juries of one's peers
D. all laws being decided by public referendum
Answer:
all laws being decided by public referendum.
Explanation:
Democracy can be defined as a government of the people, by the people and for the people.
There are two (2) main types of democracy and these include;
I. Representative democracy: it's also known as indirect democracy and can be defined as a form of government which typically involves the process of having the citizens of a particular country vote to elect representatives (political leaders) to enact laws, create policies and make decisions on their behalf.
II. Direct democracy: it can be defined as a process which typically involves the candidates voting for their preferred choice. Thus, their choices are reflected directly on the subject matter.
Hence, both representative democracy and direct democracy are forms of rule by the people. A representative democracy also involves all laws promulgated across the country being decided by public referendum i.e the entire electorate are invited and availed with the opportunity to vote on the particular law.
Answer:
D- Both option A and C
Explanation:
The Health Insurance Portability and Accountability Act of 1996 aka HIPAA facilitates the safeguarding and privacy of individuals medical information with a national set of standards to save, maintain and/or handle PHI. Due to the seriousness of PHI, individuals are allowed to agree or object the use, disclosure or sharing of such files with certain healthcare facilities.
Answer:
Surfactant increases airflow. It has this effect on airflow because it reduces resistance to lung inflation. Airflow increased as predicted.
Explanation:
Pulmonary surfactant is a complex mixture of lipids and proteins secreted by the Type II alveolar cells. The major component of surfactant, dipalmitoyl-phosphatidylcholine (DPPC), is an amphiphatic phospholipid. The main function of the pulmonary surfactant is to reduce the surface tension at the air/liquid interface in the lungs by forming lining layer between the aqueous airway liquid and the inspired air. prevents alveolar and airway collapse at end-expiration and thus allows cyclic ventilation of the lungs. It decreases surface tension in the alveoli making it easier for the alveoli to increase surface area for gas exchange. By lowering alveolar surface tension, pulmonary surfactant provides two important benefits:
(1) it increases pulmonary compliance, reducing the work of inflating the lungs; and
(2) it reduces the lungs’ tendency to recoil, so they do not collapse as readily.
